Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy

SIMPLE SUMMARY: For patients with colorectal liver metastases (CLM), it is doubtful which treatment could be better between neoadjuvant chemotherapy followed by liver resection (NEOS) and upfront surgery (UPS). Our aim was to select the candidates who may benefit more from one or another treatment d...

Descripción completa

Detalles Bibliográficos
Autores principales: Famularo, Simone, Milana, Flavio, Cimino, Matteo, Franchi, Eloisa, Giuffrida, Mario, Costa, Guido, Procopio, Fabio, Donadon, Matteo, Torzilli, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913658/
https://www.ncbi.nlm.nih.gov/pubmed/36765570
http://dx.doi.org/10.3390/cancers15030613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913658/
https://www.ncbi.nlm.nih.gov/pubmed/36765570
http://dx.doi.org/10.3390/cancers15030613

Ejemplares similares